| http://www.w3.org/ns/prov#value | - Before we begin, I would like to call your attention to the fact that this conference call and presentation may contain forward-looking statements, including but not limited to guidance with respect to expected non-GAAP cash earnings per share, expectations and plans relating to Retigabine and Taribavirin, cost reductions, sales growth and other aspects of our restructuring and growth strategies and t
|
